Skip to main content
. 2023 Apr 12;14:1074242. doi: 10.3389/fimmu.2023.1074242

Figure 9.

Figure 9

The expression of FADS2 in BC. (A, B) RT-qPCR and Western blotting to detect the expression of FADS2 in breast cancer clinical tissue samples, GAPDH acts as control. N: normal, C: Tumor. (C) Immunohistochemical analysis of FADS2 expression in breast cancer tissues and adjacent tissues. (D, E) RT-qPCR and Western blotting to detect the expression of FADS2 in breast cancer cell lines, β-actin acts as control. ns P > 0.05, * P < 0.05, ** P < 0.01, *** P < 0.001.